Search
for
Sort by
Research 181–210 of 1000+
- Skin disease is prevented but nephritis is accelerated by multiple pregnancies in autoimmune MRL/LPR mice
- Pathogenesis of Alopecia Areata and Vitiligo: Commonalities and Differences
- Research progress in the treatment of non-scarring alopecia: mechanism and treatment
- Scoping Review on the Use of Drugs Targeting JAK/STAT Pathway in Atopic Dermatitis, Vitiligo, and Alopecia Areata
- The influence of interferon on healthy and diseased skin
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- 183 PD-1 regulatory network is upregulated in contact immunotherapy during alopecia areata treatment
- Exploring the hair follicle immune privilege state in nonsegmental vitiligo
- Primary cicatricial alopecias are characterized by dysregulation of shared gene expression pathways
- Alopecia universalis with IL-12-RB1 and STAT4 mutations effectively treated with upadacitinib
- ILC3s as central regulators of mucosal homeostasis and disease pathogenesis (Review)
- In Human Skin, UVB Initiates Early Induction of IL-10 Over IL-12 Preferentially in the Expanding Dermal Monocytic/Macrophagic Population
- Proteomic Predictors of Baricitinib Response in Severe Alopecia Areata: CCL11 Flags a Refractory Phenotype
- Adipose tissue remodeling via TSLP-mediated IL-4/IL-13 signaling: Implications for atopic dermatitis and skin barrier
- Bioinformatics analysis of genes associated with the patchy-type alopecia areata: CD2 may be a new therapeutic target
- Platelet-Rich Plasma (PRP) in Dermatology: Cellular and Molecular Mechanisms of Action
- Off‐Label Use of Topical Ruxolitinib in Dermatology: A Systematic Literature Review and Current Perspectives
- Synergistic Effect of Co-Delivering Ciprofloxacin and Tetracycline Hydrochloride for Promoted Wound Healing by Utilizing Coaxial PCL/Gelatin Nanofiber Membrane
- Thymic Stromal Lymphopoietin in Cutaneous Immune-Mediated Diseases
- Chronic delayed-type hypersensitivity reaction as a means to treat alopecia areata
- Exosome-Based Therapies for Alopecia Areata: A Systematic Review of Clinical and Experimental Evidence
- Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
- Autoimmune Skin Diseases in the Era of COVID-19: Pathophysiological Insights and Clinical Implications
- Immunomodulatory properties of mesenchymal stromal/stem cells: The link with metabolism
- Dupilumab in Inflammatory Skin Diseases: A Systematic Review
- Therapeutic, Prophylactic, and Functional Use of Probiotics: A Current Perspective
- Evaluating the Therapeutic Potential of Ritlecitinib for the Treatment of Alopecia Areata
- Keratin 6A promotes skin inflammation through JAK1-STAT3 activation in keratinocytes
- Novel Janus Kinase Inhibitors in the Treatment of Dermatologic Conditions
- Astilbin Activates the Reactive Oxidative Species/PPARγ Pathway to Suppress Effector CD4+ T Cell Activities via Direct Binding With Cytochrome P450 1B1